Evidence map›Paper›PMID 41334639›Full record

ArticleHuman vaccines & immunotherapeutics2025

The vaccination status and attitudes toward human papillomavirus among gynecologists in China: A cross-sectional survey.

Yue Huang, Misi He, Ling Li, Rong Xie, Dapeng Li, Zhijun Yang, Qiaoling Li, Mingfang Guo, Jing Wang, He Hao and 5 more

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yue HuangDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
Misi HeDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
Ling LiDepartment of Gynecologic Oncology, Jiangxi Maternal and Child Health Care Hospital, Nanchang, Jiangxi, China.
Rong XieDepartment of Gynecologic Oncology, Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China.
Dapeng LiDepartment of Gynecologic Oncology, Affiliated Cancer Hospital of Shandong First Medical University, Taian, Shandong, China.
Zhijun YangDepartment of Gynecologic Oncology, Affiliated Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Qiaoling LiDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
Mingfang GuoDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
Jing WangDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
He HaoDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
Xiuying LiDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
Qian ZhengDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
Ling LongDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
Qi ZhouDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.
Dongling ZouDepartment of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gynecologists are the main group promoting vaccines. Previous studies have paid less attention to their human papillomavirus(HPV) vaccination status.Understanding their acceptance and true attitudes toward vaccines, as well as the reasons for not getting vaccinated, is of great significance for promoting vaccines. A cross-sectional survey was conducted from June to August 2024 across six Chinese cities by the Cancer Endocrinology Committee of the Chinese Anti-Cancer Association, using a convenience sampling strategy to distribute questionnaires to gynecologists in tertiary public hospitals. Results were presented as case numbers (percentages), with group comparisons made using either the χ

Indexed as

Attitude of Health PersonnelGynecologyHealth Knowledge, Attitudes, PracticePapillomavirus InfectionsPapillomavirus VaccinesVaccinationAdultChinaCross-Sectional StudiesFemaleGynecologistsHuman Papillomavirus VirusesHumansMaleMiddle AgedSurveys and QuestionnairesPapillomavirus VaccinesChinagynecologistsHPVHPV vaccinesurvey

Identifiers

PMID41334639
PMCPMC12688238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.